Yayınlar & Eserler

Yayın Ağı
Makaleler 18
Tümü (18)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (12)
Scopus (13)
TRDizin (3)
Diğer Yayınlar (1)

1. Eco-friendly synthesis of silver nanoparticles using Anemone coronaria bulb extract and their potent anticancer and antibacterial activities

Yüce M., Albayrak E., Yontar A. K., Çevik S.
SCIENTIFIC REPORTS , cilt.15, sa.32066, ss.1-16, 2025 (SCI-Expanded, Scopus)

2. The Oncogenic Role of Holliday Junction Recognition Protein in Hepatocellular Carcinoma

YÜCE M., ALBAYRAK E., ŞİŞLİ İ.
JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , 2025 (Scopus)

3. CRISPR/Cas9 mediated next generation gene therapy in chronic myeloid leukemia

Somuncu M. N., Yildirim M. S., Aydin C., Zamani A. G., Duran T., Albayrak E., et al.
INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY , cilt.63, sa.1, ss.52-65, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

4. Tonsil mesenchymal stem cells-derived exosomes differentially effect the cell proliferation depending on different temperature conditions

YÜCE M., ŞİŞLİ İ., ÇİFTCİOĞLU E., ALBAYRAK E., KIRBAŞ O. K., TAŞLI P. N., et al.
The European Research Journal , cilt.10, sa.5, ss.501-512, 2024 (TRDizin) identifier

5. Changes in stemness properties of human adenoid-derived mesenchymal stem cells during in vitro aging

Yuce M., Albayrak E., Akgül G., Yağcı N., Tekcan E.
Frontiers in Life Sciences and Related Technologies (Online) , cilt.5, sa.2, ss.122-129, 2024 (TRDizin) identifier

6. Paracrine Factors Released from Tonsil-Derived Mesenchymal Stem Cells Inhibit Proliferation of Hematological Cancer Cells Under Hyperthermia in Co-culture Model

Yüce M., Albayrak E.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY , cilt.196, sa.7, ss.4105-4124, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

7. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis

MERİÇ N., Albayrak E., Gulbas Z., Kocabas F.
LEUKEMIA & LYMPHOMA , cilt.65, sa.2, ss.187-198, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

8. Conditioned media of tonsil derived mesenchymal stem cells shows different rates of cytotoxicity on solid cancer cells

YÜCE M., ALBAYRAK E., GÜMÜŞKAPTAN Ç.
Anatolian Current Medical Journal , cilt.5, sa.4, ss.503-510, 2023 (TRDizin)

9. CRISPR/Cas9 system in hematopoietic stem cells: Basic research and clinical applications

Albayrak E.
Journal of Experimental and Clinical Medicine (Turkey) , cilt.40, sa.1, ss.161-170, 2023 (Scopus) Creative Commons License identifier

10. Mesenchymal Stem Cell Applications for the Treatment of COVID-19: Clinical Perspective

Kasaplı B. N., Duran Ş. Y., Geçit T., Albayrak E., Yüce M.
ClinMed International Library , cilt.9, 2022 (Hakemli Dergi)

11. BML-260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability

Albayrak E., Akgol S., Turan R. D., Uslu M., Kocabas F.
Journal of Cellular Biochemistry , cilt.123, sa.12, ss.2009-2029, 2022 (SCI-Expanded, Scopus) identifier identifier

12. Hyperthermia-stimulated tonsil-mesenchymal stromal cells suppress hematological cancer cells through downregulation of IL-6

Yüce M., Albayrak E.
JOURNAL OF CELLULAR BIOCHEMISTRY , cilt.123, sa.12, ss.1966-1979, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content

Uslu M., Albayrak E., KOCABAŞ F.
INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.110, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

14. Small molecule-mediated modulation of ubiquitination and neddylation improves HSC function ex vivo

Albayrak E., Uslu M., Akgol S., Tuysuz E. C., Kocabas F.
Journal of Cellular Physiology , cilt.236, sa.12, ss.8122-8136, 2021 (SCI-Expanded, Scopus) identifier identifier

15. Development of Small Molecule MEIS Inhibitors that modulate HSC activity

Turan R. D., Albayrak E., Uslu M., Siyah P., Alyazici L. Y., Kalkan B. M., et al.
Scientific Reports , cilt.10, sa.1, 2020 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

16. Temporal modulation of calcium sensing in hematopoietic stem cells is crucial for proper stem cell expansion and engraftment

Uslu M., Albayrak E., Kocabaş F.
Journal of Cellular Physiology , cilt.235, sa.12, ss.9644-9666, 2020 (SCI-Expanded, Scopus) identifier identifier

17. c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression

Aksoz M., Albayrak E., Aslan G. S., Turan R. D., Alyazici L. Y., Siyah P., et al.
Current Cancer Drug Targets , cilt.19, sa.6, ss.479-494, 2019 (SCI-Expanded, Scopus) identifier identifier

18. Emerging roles of meis1 in cardiac regeneration, stem cells and cancer

Aksöz M., Turan R. D., Albayrak E., Kocabaş F.
Current Drug Targets , cilt.19, sa.2, ss.181-190, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Comparıson of Mesenchymal Stem Cells Derived from Periapical Cysts And Dental Pulp: An In Vitro Evaluation

Pirimoğlu B., KESKİN C., YÜCE M., KESKİN M., NUHOĞLU Z., ALBAYRAK E., et al.
16.Uluslararası Türk Endodonti Derneği Kongresi, Antalya, Türkiye, 25 Mayıs 2025, (Özet Bildiri)

2. Kronik Miyeloid Lösemide CRISPR/Cas9 Aracılı Yeni Nesil Gen Tedavisi

SOMUNCU M. N., YILDIRIM S., AYDIN C., ZAMANİ A. G., ALBAYRAK E., KAVAKLI İ. H.
1.ulusal Hematoonkogenetik Kongresi, 25 Kasım 2021, (Özet Bildiri)

3. Lösemi Kök Hücrelerinde MEİS1 İfade Profilinin Belirlenmesi Ve MEİS1 İnhibitörlerin Etkisinin İncelenmesi

MERİÇ N., ALBAYRAK E., KOCABAŞ F., GÜLBAŞ Z.
47.Ulusal Hematoloji Kongresi, Antalya, Türkiye, 4 - 07 Kasım 2021, ss.252, (Özet Bildiri)

4. Role of Sialyltransferase Family in Cardiomyocyte and Hematopoietic Stem Cell Function

ALBAYRAK E., KOCABAŞ F.
2nd International Stem Cell Congress, Türkiye, 15 Ekim 2015, (Özet Bildiri)
Kitaplar 3

1. Natural product–based drug nanodelivery systems in cancertherapy

Yüce M., Albayrak E.
Studies in Natural Products Chemistry, Atta-ur-Rahman, Editör, Elsevier Science, Oxford/Amsterdam , Amsterdam, ss.41-104, 2025

2. Therapeutic targeting and HSC proliferation by small molecules and biologicals

Albayrak E., Kocabaş F.
Control of Cell Cycle & Cell Proliferation, Rossen Donev, Editör, Elsevier Science, Oxford/Amsterdam , Oxford, ss.425-496, 2023

3. Kara Mürver ve Kanser

Albayrak E., Yüce M., Gümüşkaptan Ç.
Kara Mürver: Meyve mi İlaç mı?, Hayrettin Mutlu,Elif Günalan, Editör, Nobel Yayınevi, Ankara, ss.117-146, 2022
Metrikler

Yayın

25

Yayın (WoS)

12

Yayın (Scopus)

13

Atıf (WoS)

18

H-İndeks (WoS)

3

Atıf (Scopus)

139

H-İndeks (Scopus)

6

Atıf (Scholar)

199

H-İndeks (Scholar)

6

Proje

15

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları